Charles River Laboratories CRL Future pension and postretirement benefit obligations
Future pension and postretirement benefit obligations at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's future pension and postretirement benefit obligations.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Charles River Laboratories's future pension and postretirement benefit obligations?
- Charles River Laboratories (CRL) reported future pension and postretirement benefit obligations of $66.3M in Q1 2026.
- What is the long-term trend for Charles River Laboratories's future pension and postretirement benefit obligations?
- Over 2 years (2020 to 2025), Charles River Laboratories's future pension and postretirement benefit obligations has grown at a -4.0% compound annual growth rate (CAGR), from $74.23M to $68.44M.